Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Circulating progesterone concentrations in nonlactating Holstein cows during reuse of intravaginal progesterone implants sanitized by autoclave or chemical disinfection

Texto completo
Autor(es):
Melo, L. F. [1] ; Monteiro, Jr., P. L. J. [1] ; Oliveira, L. H. [1] ; Guardieiro, M. M. [2] ; Drum, J. N. [1] ; Wiltbank, M. C. [3] ; Sartori, R. [1]
Número total de Autores: 7
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Dept Anim Sci, BR-13418900 Piracicaba, SP - Brazil
[2] Minist Agr Livestock & Food Supply, Natl Agr Lab, BR-13100105 Campinas, SP - Brazil
[3] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 - USA
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: JOURNAL OF DAIRY SCIENCE; v. 101, n. 4, p. 3537-3544, APR 2018.
Citações Web of Science: 2
Resumo

The aim of this study was to compare plasma progesterone (P4) concentrations in nonlactating, multiparous Holstein cows (n = 24) treated with 2 types of intravaginal implants containing either 1.0 or 1.9 g of P4 either at the first use or during reuse of the implants after sanitizing the implant by autoclave or chemical disinfection. In a completely randomized design with a 2 x 3 factorial arrangement and 2 replicates, every cow underwent 2 of 6 treatments. Two sources of P4 {[}controlled internal drug release (1.9 g of P4) from Zoetis (Sao Paulo, Brazil), and Sincrogest (1.0 g of P4) from Ourofino (Cravinhos, Brazil)] and 3 types of processing, new (N), reused after autoclave (RA), and reused after chemical disinfection (RC), were used. After inducing luteolysis to avoid endogenous circulating P4, the cows were randomized in 1 of 6 treatments (1.9 g of N, 1.9 g of RA, 1.9 g of RC, 1.0 g of N, 1.0 g of RA, and 1.0 g RC). Cows were treated with the implants for 8 d and during this period blood samples were collected at 0, 2, 12, 24, 48, 72, 96, 120, 144, 168, and 192 h. Statistical analyses were performed using Proc-Mixed and the mean +/- standard error of the mean P4 concentrations were calculated using the Proc-Means procedures of SAS 9.4 (SAS Institute Inc., Cary, NC). No interaction between treatments was observed. Comparing types of implant, average P4 concentrations during treatments were greater for 1.9 g than 1.0 g (1.46 vs. 1.14 +/- 0.04 ng/mL). When types of processing were compared, average P4 concentrations did not differ between autoclaved and new inserts (1.46 vs. 1.37 +/- 0.05 ng/mL; respectively), but both were greater than chemically disinfected implants (1.09 +/- 0.04 ng/mL). Within 1.9-g P4 inserts, P4 concentrations from autoclaved implants were greater than new, which were greater than chemically disinfected (1.67 +/- 0.06 vs. 1.49 +/- 0.07 vs. 1.21 +/- 0.05 ng/mL; respectively). For 1.0-g P4 implants, P4 concentrations from autoclaved did not differ from new, but both were greater than chemically disinfected (1.20 +/- 0.08 vs. 1.24 +/- 0.06 vs. 0.97 +/- 0.05 ng/mL; respectively). In conclusion, the mean plasma P4 concentration in nonlactating Holstein cows was greater for 1.9 than 1.0 g of P4 and regardless of the type of implant, the autoclaving process provided greater circulating P4 in relation to chemical disinfection, and similar or greater P4 concentrations compared with a new implant. (AU)

Processo FAPESP: 11/11395-0 - Aprimoramento de protocolos de manejo reprodutivo à base de hormônios exógenos para elevar a fertilidade de vacas leiteiras de alta produção
Beneficiário:Roberto Sartori Filho
Modalidade de apoio: Auxílio à Pesquisa - Regular